Our Policies

User Fees

Our user fees are essential for the availability of the instrumentation and expertise that the ARC provides.  We aim to set our user fees at the lowest possible level to maintain our resources.  As a consequence, ARC user fees may be adjusted to reflect current funding situations.

Training and Facilities Access

Where training and self-use of ARC instruments is offered, users are expected to adhere to all safety and user guidelines, as requested by ARC and their staff.  Please contact us for specific user guidelines. ARC can revoke facility and instrument access at any time due to non-compliance.

It is the responsibility of the PI submitting or running the samples to have the appropriate protocol approval for projects involving the analysis of human, animal, or infectious materials. For full-service work, you will be required to submit information describing and safety concerns associated with the sample as part of the iLab project submission process.

External User Guidelines and Policy

We regularly perform services for external (to CSU) users, for both full and self-service.  Please see our Guidelines for External Users document for more information.

Certification

Our instruments are operated and services conducted under commonly accepted research practices.  ARC does not perform any services that may be subject to FDA Regulations (e.g. GMP, cGMP, GLP, GCP).

Publications

If you publish using data or tools generated within our Core Services, please:

• Please cite or acknowledge us by our Research Resource ID (RRID: SCR_021758) in publications that include any data generated in or by our facility.  If appropriate, consider acknowledging the specific ARC employee(s) by name. 
• Consider authorship for more significant intellectual and planning contributions by ARC scientific staff. Co-authorship is generally expected when ARC personnel have made significant contributions to the research in the form of consultation, experimental design, method development, data analysis and/or data interpretation.  ‘Significant’ can be defined as “the project would not have progressed, or progressed at a substantially slower pace, without the guidance of facility personnel”.  In such cases, ARC personnel should have the opportunity to review and edit the appropriate sections of a manuscript before submission.
• We have been fortunate to have instruments funded through federal programs.  If your work uses these instruments, please acknowledge them in your publications.   
  
  • The Bruker UltrafleXtreme was funded by the NSF-MRI program (award 2117934).
  • The Thermo Scientific Orbitrap Eclipse was funded by the NSF MRI program (award 2117943).